Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-APC antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3-PE antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). |
Figure 1Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-APC antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3-PE antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). | Figure 1Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-APC antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3-PE antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). |
Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-PE antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3 -Vio ® 667 antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). |
Figure 2Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-PE antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3 -Vio ® 667 antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). | Figure 2Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-PE antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3 -Vio ® 667 antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). |
Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-APC antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3-PE antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). |
Figure 1Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-APC antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3-PE antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). | Figure 1Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-APC antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3-PE antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). |
Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-PE antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3 -Vio ® 667 antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). |
Figure 2Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-PE antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3 -Vio ® 667 antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). | Figure 2Mouse lymph nodes were stained with CD4-VioBlue ® and CD25-PE antibodies. Cells were fixed, permeabilized, and stained with Anti-FoxP3 -Vio ® 667 antibodies. Cells were analyzed by flow cytometry. Autofluorescent cell debris was excluded in an FL-2 versus FL-3 dot plot (data not shown). Gating was performed according to CD4 expression (except for the CD4/Anti-FoxP3 dot plot). |
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.